Pulmonary hypertension: what can we learn from studies? Source: International Congress 2015 – Practising personalised medicine: why, when, and how? Year: 2015
Pathophysiology of pulmonary hypertension: what the interested clinician needs to know Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020
Goal-oriented therapy in paediatric pulmonary arterial hypertension: are we ready? Source: Eur Respir J 2014; 44: 1404-1407 Year: 2014
Debating the new haemodynamic definition of pulmonary hypertension: much ado about nothing? Source: Eur Respir J, 54 (2) 1901278; 10.1183/13993003.01278-2019 Year: 2019
Making the diagnosis of acute pulmonary embolism: what do the guidelines say? Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020
Assessing risk in pulmonary arterial hypertension: what we know, what we don't Source: Eur Respir J, 50 (2) 1701353; 10.1183/13993003.01353-2017 Year: 2017
“Rehab for all!” Is it too early in pulmonary arterial hypertension? Source: Eur Respir J, 54 (5) 1901558; 10.1183/13993003.01558-2019 Year: 2019
Pulmonary arterial hypertension among elderly patients: an emerging problem? Source: Annual Congress 2007 - Pulmonary hypertension in the clinic Year: 2007
Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2017
Clinical trials in pulmonary arterial hypertension: what they tell us Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease Year: 2020
Clinical trials in pulmonary arterial hypertension: what do they tell us Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease Year: 2018
Pulmonary embolism and pulmonary hypertension - is our follow up adequate? Source: Eur Respir J 2005; 26: Suppl. 49, 270s Year: 2005
Chronic thromboembolic pulmonary hypertension: do we need a new definition? Source: Eur Respir J 2014; 44: 1401-1403 Year: 2014
Is right heart catheterisation still a fundamental part of the follow-up assessment of pulmonary arterial hypertension? The argument against Source: Eur Respir J, 52 (1) 1800996; 10.1183/13993003.00996-2018 Year: 2018
What can the ECG tell us about pulmonary embolism? Source: Eur Respir J 2004; 24: Suppl. 48, 274s Year: 2004
Thrombo-embolic pulmonary hypertension: which treatment should we choose? /
Hypertension pulmonaire thrombo-embolique: quel traitement choisir ? Source: International Congress 2018 – French Programme 2018: Part II Year: 2018
Treatment of pulmonary hypertension due to COPD: can we really hope in better? Source: Eur Respir J 2005; 26: Suppl. 49, 562s Year: 2005
Learning to pair therapies and the expanding matrix for pulmonary arterial hypertension: is more better? Source: Eur Respir J 2006 Oct 01;28(4):683-686 Year: 2006
Physicians’ and patients’ expectations of therapies for pulmonary arterial hypertension: where do they meet? Source: Eur Respir Rev 2014; 23: 458-468 Year: 2014
Pulmonary arterial hypertension or left heart disease with pulmonary hypertension? Toward noninvasive clarity, but time for a new paradigm Source: Eur Respir J 2015; 46: 299-302 Year: 2015